ScholarLens Back to search
1999•PubMedRequires access

Treatment of mesangial immunoglobulin A glomerulonephritis.

P Kincaid-Smith

Open publisher page 8 citations

Abstract

Mesangial immunoglobulin A glomerulonephritis does not progress unless microscopic hematuria presents at levels over 100,000/mL, proteinuria presents at levels over 0.5 g in 24 hours, or hypertension is inadequately controlled. Hypertension, microscopic hematuria, and proteinuria all can be controlled; the evidence for control of these three risk factors is reviewed. The evidence for prevention of progression in mesangial immunoglobulin A glomerulonephritis is also reviewed.

About this research paper

What this paper is about

Mesangial immunoglobulin A glomerulonephritis does not progress unless microscopic hematuria presents at levels over 100,000/mL, proteinuria presents at levels over 0.5 g in 24 hours, or hypertension is inadequately controlled. Hypertension, microscopic hematuria, and proteinuria all can be controlled; the evidence for control of these three risk factors is reviewed. The evidence for prevention of progression in mesangial immunoglobulin A glomerulonephritis is also reviewed.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Mesangial immunoglobulin A glomerulonephritis does not progress unless microscopic hematuria presents at levels over 100,000/mL, proteinuria presents at levels over 0.5 g in 24 hours, or hypertension is inadequately controlled. Hypertension, microscopic hematuria, and proteinuria all can be controlled; the evidence for control of these three risk factors is reviewed. The evidence for prevention of progression in mesangial immunoglobulin A glomerulonephritis is also reviewed.

Key concepts: Proteinuria, Glomerulonephritis, Medicine, Microscopic hematuria, Mesangial proliferative glomerulonephritis, Immunoglobulin A, Antibody, Immunoglobulin G

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Treatment of mesangial immunoglobulin A glomerulonephritis. — Research Paper | ScholarLens